Pleural diseases related to metastatic malignancies

Pleural effusions associated with malignancy (either malignant or paramalignant) pose diagnostic and therapeutic dilemmas for the clinician. This article reviews the common causes of malignant and paramalignant pleural effusions, pathogenesis, clinical presentation, chest radiography, pleural fluid characteristics, diagnosis, prognosis, and treatment. Talc, used either by poudrage or slurry, is the most effective agent used for pleurodesis. Talc, which needs to be sterilized, has no clinically important immediate, short-term or long-term adverse effects.

This article has been cited by other articles:

				W. Abouzgheib, T. Bartter, H. Dagher, M. Pratter, and W. Klump A Prospective Study of the Volume of Pleural Fluid Required for Accurate Diagnosis of Malignant Pleural Effusion Chest, April 1, 2009; 135(4): 999 - 1001. [Abstract] [Full Text] [PDF]

				B. Chakrabarti, I. Ryland, J. Sheard, C. J. Warburton, and J. E. Earis The Role of Abrams Percutaneous Pleural Biopsy in the Investigation of Exudative Pleural Effusions Chest, June 1, 2006; 129(6): 1549 - 1555. [Abstract] [Full Text] [PDF]

				J. Ferrer, J. Roldan, J. Teixidor, E. Pallisa, I. Gich, and F. Morell Predictors of Pleural Malignancy in Patients With Pleural Effusion Undergoing Thoracoscopy Chest, March 1, 2005; 127(3): 1017 - 1022. [Abstract] [Full Text] [PDF]

				C.-F. Chian, W.-L. Su, L.-H. Soh, H.-C. Yan, W.-C. Perng, and C.-P. Wu Echogenic Swirling Pattern as a Predictor of Malignant Pleural Effusions in Patients With Malignancies Chest, July 1, 2004; 126(1): 129 - 134. [Abstract] [Full Text] [PDF]

				G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]

				Y. van Hensbergen, H. J. Broxterman, R. Hanemaaijer, A. S. Jorna, N. A. van Lent, H. M. W. Verheul, H. M. Pinedo, and K. Hoekman Soluble Aminopeptidase N/CD13 in Malignant and Nonmalignant Effusions and Intratumoral Fluid Clin. Cancer Res., December 1, 2002; 8(12): 3747 - 3754. [Abstract] [Full Text] [PDF]

				V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn Management of malignant pleural effusions Eur. Respir. J., August 1, 2001; 18(2): 402 - 419. [Full Text] [PDF]

				G. W. Pien, M. J. Gant, C. L. Washam, and D. H. Sterman Use of an Implantable Pleural Catheter for Trapped Lung Syndrome in Patients With Malignant Pleural Effusion Chest, June 1, 2001; 119(6): 1641 - 1646. [Abstract] [Full Text] [PDF]

				Y C G Lee, K B Lane, R E Parker, D S Ayo, J T Rogers, R W Diters, P J Thompson, and R W Light Transforming growth factor beta 2 (TGFbeta 2) produces effective pleurodesis in sheep with no systemic complications Thorax, December 1, 2000; 55(12): 1058 - 1062. [Abstract] [Full Text]

				Management of Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001. [Full Text]

				R. Kaarteenaho–Wiik, E. Lakari, Y. Soini, R. Pöllänen, V. L. Kinnula, and P. Pääkkö Tenascin Expression and Distribution in Pleural Inflammatory and Fibrotic Diseases J. Histochem. Cytochem., September 1, 2000; 48(9): 1257 - 1268. [Abstract] [Full Text]

				H.M.W. Verheul, K. Hoekman, A.S. Jorna, E.F. Smit, and H.M. Pinedo Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion Formation Oncologist, April 1, 2000; 5(90001): 45 - 50. [Abstract] [Full Text]

				L. Kraus-Berthier, M. Jan, N. Guilbaud, M. Naze, A. Pierré, and G. Atassi Histology and Sensitivity to Anticancer Drugs of Two Human Non-Small Cell Lung Carcinomas Implanted in the Pleural Cavity of Nude Mice Clin. Cancer Res., January 1, 2000; 6(1): 297 - 304. [Abstract] [Full Text]

				D.-s. Cheng, R. M. Rodriguez, E. A. Perkett, J. Rogers, G. Bienvenu, U. Lappalainen, and R. W. Light Vascular Endothelial Growth Factor in Pleural Fluid Chest, September 1, 1999; 116(3): 760 - 765. [Abstract] [Full Text] [PDF]